These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

310 related items for PubMed ID: 32162301

  • 1. Long-term follow-up of the randomized trial of mesorectal excision with or without lateral lymph node dissection in rectal cancer (JCOG0212).
    Tsukamoto S, Fujita S, Ota M, Mizusawa J, Shida D, Kanemitsu Y, Ito M, Shiomi A, Komori K, Ohue M, Akazai Y, Shiozawa M, Yamaguchi T, Bando H, Tsuchida A, Okamura S, Akagi Y, Takiguchi N, Saida Y, Akasu T, Moriya Y, Colorectal Cancer Study Group of Japan Clinical Oncology Group.
    Br J Surg; 2020 Apr; 107(5):586-594. PubMed ID: 32162301
    [Abstract] [Full Text] [Related]

  • 2. Mesorectal Excision With or Without Lateral Lymph Node Dissection for Clinical Stage II/III Lower Rectal Cancer (JCOG0212): A Multicenter, Randomized Controlled, Noninferiority Trial.
    Fujita S, Mizusawa J, Kanemitsu Y, Ito M, Kinugasa Y, Komori K, Ohue M, Ota M, Akazai Y, Shiozawa M, Yamaguchi T, Bandou H, Katsumata K, Murata K, Akagi Y, Takiguchi N, Saida Y, Nakamura K, Fukuda H, Akasu T, Moriya Y, Colorectal Cancer Study Group of Japan Clinical Oncology Group.
    Ann Surg; 2017 Aug; 266(2):201-207. PubMed ID: 28288057
    [Abstract] [Full Text] [Related]

  • 3. Postoperative morbidity and mortality after mesorectal excision with and without lateral lymph node dissection for clinical stage II or stage III lower rectal cancer (JCOG0212): results from a multicentre, randomised controlled, non-inferiority trial.
    Fujita S, Akasu T, Mizusawa J, Saito N, Kinugasa Y, Kanemitsu Y, Ohue M, Fujii S, Shiozawa M, Yamaguchi T, Moriya Y, Colorectal Cancer Study Group of Japan Clinical Oncology Group.
    Lancet Oncol; 2012 Jun; 13(6):616-21. PubMed ID: 22591948
    [Abstract] [Full Text] [Related]

  • 4. Male sexual dysfunction after rectal cancer surgery: Results of a randomized trial comparing mesorectal excision with and without lateral lymph node dissection for patients with lower rectal cancer: Japan Clinical Oncology Group Study JCOG0212.
    Saito S, Fujita S, Mizusawa J, Kanemitsu Y, Saito N, Kinugasa Y, Akazai Y, Ota M, Ohue M, Komori K, Shiozawa M, Yamaguchi T, Akasu T, Moriya Y, Colorectal Cancer Study Group of Japan Clinical Oncology Group.
    Eur J Surg Oncol; 2016 Dec; 42(12):1851-1858. PubMed ID: 27519616
    [Abstract] [Full Text] [Related]

  • 5. Predictive factors of pathological lateral pelvic lymph node metastasis in patients without clinical lateral pelvic lymph node metastasis (clinical stage II/III): The analysis of data from the clinical trial (JCOG0212).
    Komori K, Fujita S, Mizusawa J, Kanemitsu Y, Ito M, Shiomi A, Ohue M, Ota M, Akazai Y, Shiozawa M, Yamaguchi T, Bandou H, Katsumata K, Kinugasa Y, Takii Y, Akasu T, Moriya Y, Colorectal Cancer Study Group of Japan Clinical Oncology Group.
    Eur J Surg Oncol; 2019 Mar; 45(3):336-340. PubMed ID: 30477950
    [Abstract] [Full Text] [Related]

  • 6. Selective lateral lymph node dissection after neoadjuvant chemoradiotherapy in rectal cancer.
    Chen JN, Liu Z, Wang ZJ, Mei SW, Shen HY, Li J, Pei W, Wang Z, Wang XS, Yu J, Liu Q.
    World J Gastroenterol; 2020 Jun 07; 26(21):2877-2888. PubMed ID: 32550762
    [Abstract] [Full Text] [Related]

  • 7. The influence of neoadjuvant chemoradiotherapy combined with lateral lymph nodes dissection or not on the local recurrence of low to intermediate-stage II/III rectal cancer.
    Li C, Luan J, Ji X, Wang X, Li J, Li X, Zhou Y.
    J Surg Oncol; 2024 Feb 07; 129(2):273-283. PubMed ID: 37811551
    [Abstract] [Full Text] [Related]

  • 8. Urinary dysfunction after rectal cancer surgery: Results from a randomized trial comparing mesorectal excision with and without lateral lymph node dissection for clinical stage II or III lower rectal cancer (Japan Clinical Oncology Group Study, JCOG0212).
    Ito M, Kobayashi A, Fujita S, Mizusawa J, Kanemitsu Y, Kinugasa Y, Komori K, Ohue M, Ota M, Akazai Y, Shiozawa M, Yamaguchi T, Akasu T, Moriya Y, Colorectal Cancer Study Group of Japan Clinical Oncology Group.
    Eur J Surg Oncol; 2018 Apr 07; 44(4):463-468. PubMed ID: 29428473
    [Abstract] [Full Text] [Related]

  • 9. Exploratory analysis of lateral pelvic sentinel lymph node status for optimal management of laparoscopic lateral lymph node dissection in advanced lower rectal cancer without suspected lateral lymph node metastasis.
    Yasui M, Ohue M, Noura S, Miyoshi N, Takahashi Y, Matsuda C, Nishimura J, Haraguchi N, Ushigome H, Nakai N, Fujino S, Sugimura K, Wada H, Takahashi H, Omori T, Miyata H.
    BMC Cancer; 2021 Aug 11; 21(1):911. PubMed ID: 34380428
    [Abstract] [Full Text] [Related]

  • 10. Lateral lymph node dissection reduces local recurrence of locally advanced lower rectal cancer in the absence of preoperative neoadjuvant chemoradiotherapy: a systematic review and meta-analysis.
    Gao X, Wang C, Yu Y, Singh D, Yang L, Zhou Z.
    World J Surg Oncol; 2020 Nov 23; 18(1):304. PubMed ID: 33228677
    [Abstract] [Full Text] [Related]

  • 11. Clinical influence of prophylactic lateral lymph node dissection on oncologic outcomes of patients with mid-low rectal cancer undergoing mesorectal excision: a meta-analysis.
    Ishizuka M, Shibuya N, Hachiya H, Nishi Y, Takayanagi M, Fujita J, Ihara K, Shiraki T, Matsumoto T, Mori S, Iso Y, Nakamura T, Aoki T, Irisawa A.
    J Gastrointest Surg; 2024 Apr 23; 28(4):548-558. PubMed ID: 38583909
    [Abstract] [Full Text] [Related]

  • 12. [Short-term efficacy of robotic-assisted total mesorectal excision with and without lateral lymph node dissection for mid-low advanced rectal cancer: a propensity score matching analysis].
    Shi FY, Zhang L, Qin Q, Jin X, Hu CH, Yu TY, Ma L, Wang GH, Wu H, Xia P, Sun XJ, She JJ.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Apr 25; 23(4):370-376. PubMed ID: 32306605
    [Abstract] [Full Text] [Related]

  • 13. Significance of lateral lymph node dissection in squamous cell carcinoma of the anal canal: a retrospective cohort study.
    Komori K, Yamada K, Ajioka Y, Sugihara K.
    Langenbecks Arch Surg; 2024 May 13; 409(1):157. PubMed ID: 38735992
    [Abstract] [Full Text] [Related]

  • 14. Is prophylactic lateral lymph node dissection needed for lower rectal cancer? A single-center retrospective study.
    Kondo H, Yamaguchi S, Hirano Y, Aikawa M, Sato H, Okamoto K, Sakuramoto S, Koyama I.
    BMC Surg; 2021 May 26; 21(1):261. PubMed ID: 34039328
    [Abstract] [Full Text] [Related]

  • 15. Potential impact of lateral lymph node dissection (LLND) for low rectal cancer on prognoses and local control: A comparison of 2 high-volume centers in Japan that employ different policies concerning LLND.
    Kanemitsu Y, Komori K, Shida D, Ochiai H, Tsukamoto S, Kinoshita T, Moriya Y.
    Surgery; 2017 Aug 26; 162(2):303-314. PubMed ID: 28366499
    [Abstract] [Full Text] [Related]

  • 16. Lateral pelvic lymph node dissection after neoadjuvant chemo-radiation for preoperative enlarged lateral nodes in advanced low rectal cancer: study protocol for a randomized controlled trial.
    Wei M, Wu Q, Fan C, Li Y, Chen X, Zhou Z, Han J, Wang Z.
    Trials; 2016 Nov 25; 17(1):561. PubMed ID: 27884204
    [Abstract] [Full Text] [Related]

  • 17. Local recurrences in western low rectal cancer patients treated with or without lateral lymph node dissection after neoadjuvant (chemo)radiotherapy: An international multi-centre comparative study.
    Kroon HM, Malakorn S, Dudi-Venkata NN, Bedrikovetski S, Liu J, Kenyon-Smith T, Bednarski BK, Ogura A, van de Velde CJH, Rutten HJT, Beets GL, Thomas ML, Kusters M, Chang GJ, Sammour T.
    Eur J Surg Oncol; 2021 Sep 25; 47(9):2441-2449. PubMed ID: 34120810
    [Abstract] [Full Text] [Related]

  • 18. Oncological Impact of Lateral Lymph Node Dissection After Preoperative Chemoradiotherapy in Patients with Rectal Cancer.
    Kim MJ, Chang GJ, Lim HK, Song MK, Park SC, Sohn DK, Chang HJ, Kim DY, Park JW, Jeong SY, Oh JH.
    Ann Surg Oncol; 2020 Sep 25; 27(9):3525-3533. PubMed ID: 32385767
    [Abstract] [Full Text] [Related]

  • 19. Prognostic impact of lateral sentinel lymph node biopsy using indocyanine green on oncological outcomes for clinical stage II/III lower rectal cancer without suspected lateral lymph node metastasis.
    Sueda T, Yasui M, Nishimura J, Kagawa Y, Kitakaze M, Mori R, Noura S, Omori T, Miyata H, Ohue M.
    Langenbecks Arch Surg; 2024 Oct 18; 409(1):311. PubMed ID: 39422803
    [Abstract] [Full Text] [Related]

  • 20. Oncological outcomes of lateral lymph node dissection (LLND) for locally advanced rectal cancer: is LLND alone sufficient?
    Ishibe A, Watanabe J, Suwa Y, Suzuki S, Nakagawa K, Suwa H, Ozawa M, Ota M, Fujii S, Ike H, Ichikawa Y, Endo I.
    Int J Colorectal Dis; 2021 Feb 18; 36(2):293-301. PubMed ID: 32965528
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.